tariquidar has been researched along with mk 0571 in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (mk 0571) | Trials (mk 0571) | Recent Studies (post-2010) (mk 0571) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 5 | 0 | 3 |
| Protein | Taxonomy | tariquidar (IC50) | mk 0571 (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 7.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhardt, G; Buschauer, A; König, B; Obreque-Balboa, JE; Sun, Q | 1 |
1 other study(ies) available for tariquidar and mk 0571
| Article | Year |
|---|---|
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.
Topics: Amination; Animals; Cell Line; Flavonoids; Humans; MCF-7 Cells; Mice; Multidrug Resistance-Associated Proteins; Pyrazoles; Pyrimidines | 2016 |